Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Depressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study.

Marrero DG, Ma Y, de Groot M, Horton ES, Price DW, Barrett-Connor E, Carnethon MR, Knowler WC; Diabetes Prevention Program Research Group.

Psychosom Med. 2015 Apr;77(3):303-10. doi: 10.1097/PSY.0000000000000156.

2.

The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up.

Aroda VR, Christophi CA, Edelstein SL, Zhang P, Herman WH, Barrett-Connor E, Delahanty LM, Montez MG, Ackermann RT, Zhuo X, Knowler WC, Ratner RE; Diabetes Prevention Program Research Group.

J Clin Endocrinol Metab. 2015 Apr;100(4):1646-53. doi: 10.1210/jc.2014-3761. Epub 2015 Feb 23.

3.

Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study.

Marrero D, Pan Q, Barrett-Connor E, de Groot M, Zhang P, Percy C, Florez H, Ackermann R, Montez M, Rubin RR; DPPOS Research Group.

Qual Life Res. 2014 Feb;23(1):75-88. doi: 10.1007/s11136-013-0436-3. Epub 2013 May 26.

4.

Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study.

Diabetes Prevention Program Outcomes Study Research Group, Orchard TJ, Temprosa M, Barrett-Connor E, Fowler SE, Goldberg RB, Mather KJ, Marcovina SM, Montez M, Ratner RE, Saudek CD, Sherif H, Watson KE.

Diabet Med. 2013 Jan;30(1):46-55. doi: 10.1111/j.1464-5491.2012.03750.x.

5.

Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.

Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE; Diabetes Prevention Program Research Group.

Lancet. 2012 Jun 16;379(9833):2243-51. doi: 10.1016/S0140-6736(12)60525-X. Epub 2012 Jun 9.

6.

Antidepressants may mitigate the effects of prenatal maternal anxiety on infant auditory sensory gating.

Hunter SK, Mendoza JH, D'Anna K, Zerbe GO, McCarthy L, Hoffman C, Freedman R, Ross RG.

Am J Psychiatry. 2012 Jun;169(6):616-24. doi: 10.1176/appi.ajp.2012.11091365.

7.

The occurrence of preterm delivery is linked to pregnancy-specific distress and elevated inflammatory markers across gestation.

Coussons-Read ME, Lobel M, Carey JC, Kreither MO, D'Anna K, Argys L, Ross RG, Brandt C, Cole S.

Brain Behav Immun. 2012 May;26(4):650-9. doi: 10.1016/j.bbi.2012.02.009. Epub 2012 Mar 7.

8.

The adult galactosemic phenotype.

Waisbren SE, Potter NL, Gordon CM, Green RC, Greenstein P, Gubbels CS, Rubio-Gozalbo E, Schomer D, Welt C, Anastasoaie V, D'Anna K, Gentile J, Guo CY, Hecht L, Jackson R, Jansma BM, Li Y, Lip V, Miller DT, Murray M, Power L, Quinn N, Rohr F, Shen Y, Skinder-Meredith A, Timmers I, Tunick R, Wessel A, Wu BL, Levy H, Elsas L, Berry GT.

J Inherit Metab Dis. 2012 Mar;35(2):279-86. doi: 10.1007/s10545-011-9372-y. Epub 2011 Jul 21.

9.

Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study.

Rubin RR, Ma Y, Peyrot M, Marrero DG, Price DW, Barrett-Connor E, Knowler WC; Diabetes Prevention Program Research Group.

Diabetes Care. 2010 Dec;33(12):2549-51. doi: 10.2337/dc10-1033. Epub 2010 Aug 30.

10.

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.

Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM.

Lancet. 2009 Nov 14;374(9702):1677-86. doi: 10.1016/S0140-6736(09)61457-4. Epub 2009 Oct 29. Erratum in: Lancet. 2009 Dec 19;374(9707):2054.

11.

Activation of corticotropin-releasing factor receptor 2 in lateral septum negatively regulates maternal defense.

D'Anna KL, Gammie SC.

Behav Neurosci. 2009 Apr;123(2):356-68. doi: 10.1037/a0014987.

PMID:
19331459
12.

Neurotensin inversely modulates maternal aggression.

Gammie SC, D'Anna KL, Gerstein H, Stevenson SA.

Neuroscience. 2009 Feb 18;158(4):1215-23. doi: 10.1016/j.neuroscience.2008.11.045. Epub 2008 Dec 7.

13.

Maternal profiling of corticotropin-releasing factor receptor 2 deficient mice in association with restraint stress.

D'Anna KL, Stevenson SA, Gammie SC.

Brain Res. 2008 Nov 19;1241:110-21. doi: 10.1016/j.brainres.2008.08.071. Epub 2008 Sep 4.

14.

Altered dopamine signaling in naturally occurring maternal neglect.

Gammie SC, Edelmann MN, Mandel-Brehm C, D'Anna KL, Auger AP, Stevenson SA.

PLoS One. 2008 Apr 9;3(4):e1974. doi: 10.1371/journal.pone.0001974.

15.

Hypocretin-1 dose-dependently modulates maternal behaviour in mice.

D'Anna KL, Gammie SC.

J Neuroendocrinol. 2006 Aug;18(8):553-66.

16.

Electromyographic analysis of traditional and nontraditional abdominal exercises: implications for rehabilitation and training.

Escamilla RF, Babb E, DeWitt R, Jew P, Kelleher P, Burnham T, Busch J, D'Anna K, Mowbray R, Imamura RT.

Phys Ther. 2006 May;86(5):656-71.

PMID:
16649890
17.

Urocortin 1 and 3 impair maternal defense behavior in mice.

D'Anna KL, Stevenson SA, Gammie SC.

Behav Neurosci. 2005 Aug;119(4):1061-71.

PMID:
16187834
18.

Elevated stress sensitivity in corticotropin-releasing factor receptor 2 deficient mice decreases maternal, but not intermale aggression.

Gammie SC, Hasen NS, Stevenson SA, Bale TL, D'Anna KL.

Behav Brain Res. 2005 May 7;160(1):169-77. Epub 2004 Dec 29.

PMID:
15836912

Supplemental Content

Loading ...
Support Center